Norio Kohno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Norio Kohno has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Akiko Okamoto
Department of Breast Surgery, Kobe Kaisei Hospital, 3-11-15 Shinohara-Kitamachi, Nada-ku, Kobe, Hyogo, 657-0068, Japan
1 shared publication- Akiko Okamoto
Department of Breast Surgery, Konan Medical Center, 1-5-16 Kamokogahara, Higashinada-Ku, Kobe City, Hyogo 658-0064, Japan
1 shared publication Hirokazu Tanino
Department of Breast Surgery, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan
1 shared publication- Jun Horiguchi
Department of Psychiatry, Shimane University Faculty of Medicine, 89-1 Enya-cho, Izumo 693-8501, Japan
1 shared publication Katsuichiro Kamimura
1 shared publicationKunio Ito
1 shared publication
Latest Publications
- Open Access
- 20 April 2021
- Published by Springer Nature in Surgical Case Reports
- Vol. 7 (1) , 1-6
A case of contralateral inguinal lymph node metastases from breast cancer
Background: Breast cancer is well known to tends to invade through the lymphatic chains mainly to the axillary and subclavian nodes or occasionally to the internal mammary nodes. However, inguinal lymph node metastasis from breast cancer is extremely rare. Case presentation: We have experienced a case of an 82-year-old woman showing left inguinal lymph node metastases from right breast cancer. Previously, she had received five times abdominal operations and left artificial bone head replacement for metamorphous hip-joint disease. Although the metastases were firstly detected 46 months after the breast surgery, they had already existed at the time of the breast operation, which was retrospectively re-evaluated by CT examination. The progression pattern of inguinal lymph node metastases had much correlated with that of the breast cancer. She underwent inguinal lymph node dissections. Pathological findings revealed them being compatible with breast cancer origin. Conclusions: This is the sixth case having been reported in English literature. Besides, this is the first case showing the contralateral spread to the primary breast cancer. One of the causes of this complex metastatic pattern is thought be ascribed to the previously performed prolific abdominal operations.
- 20 April 2021
- Published by Springer Nature in Surgical Case Reports
- Vol. 7 (1) , 1-6
Open AccessA case of contralateral inguinal lymph node metastases from breast cancer
Background: Breast cancer is well known to tends to invade through the lymphatic chains mainly to the axillary and subclavian nodes or occasionally to the internal mammary nodes. However, inguinal lymph node metastasis from breast cancer is extremely rare. Case presentation: We have experienced a case of an 82-year-old woman showing left inguinal lymph node metastases from right breast cancer. Previously, she had received five times abdominal operations and left artificial bone head replacement for metamorphous hip-joint disease. Although the metastases were firstly detected 46 months after the breast surgery, they had already existed at the time of the breast operation, which was retrospectively re-evaluated by CT examination. The progression pattern of inguinal lymph node metastases had much correlated with that of the breast cancer. She underwent inguinal lymph node dissections. Pathological findings revealed them being compatible with breast cancer origin. Conclusions: This is the sixth case having been reported in English literature. Besides, this is the first case showing the contralateral spread to the primary breast cancer. One of the causes of this complex metastatic pattern is thought be ascribed to the previously performed prolific abdominal operations.
- Open Access
- 1 June 2020
- Published by Springer Nature in Surgical Case Reports
- Vol. 6 (1) , 1-4
Chyle leakage after axillary node sampling in a patient with breast cancer: a case report
Background: Chyle leakage is a well-known complication after thoracic surgery, such as esophagectomy, cardiac surgery, mediastinal lymph node dissection, and neck surgery. However, chyle leakage is a rare complication after dissections of the lateral or subclavian axillary nodes for breast surgery. It is particularly unusual for chyle leakage to occur after minimally invasive dissection of the axillary nodes. Most cases of chyle leakage subside with conservative management, but some cases require surgery. Case report: An 80-year-old woman had invasive lobular cancer of the left breast (cT1 [1.7 cm], cN0, M0) for which she underwent breast-conservative surgery and biopsy of an axillary sentinel lymph node. Because two of the three sentinel lymph nodes tested positive for cancer, seven lateral axillary lymph nodes (level I) were subsequently removed for the additional sampling. On postoperative day 11, the patient visited our outpatient clinic because of swelling in her left axillary region and breast. Centesis of the axilla yielded 670 mL of milky fluid, which suggested chyle leakage. We commenced the conservative management at first; however, the persistent leakage made us perform the surgical management. The operation was not only ligating the opening of the chyle duct but needed total mastectomy because the postoperative pathology report showed invasive lobular carcinoma; the nipple and the caudal surgical margin of the lumpectomy were positive for cancer. The patient agreed to our recommendation of total mastectomy and surgical management of the chyle leakage. Ligation of the opening completely resolved the chylous discharge. Conclusion: We here report a case of large-volume leakage of chyle after sampling dissection of the lateral axillary lymph nodes for left breast cancer; the leakage persisted despite the standard conservative therapy but was resolved after surgical treatment. Chyle leakage can occur even after minimally invasive dissection of the axillary nodes.
- 1 June 2020
- Published by Springer Nature in Surgical Case Reports
- Vol. 6 (1) , 1-4
Open AccessChyle leakage after axillary node sampling in a patient with breast cancer: a case report
Background: Chyle leakage is a well-known complication after thoracic surgery, such as esophagectomy, cardiac surgery, mediastinal lymph node dissection, and neck surgery. However, chyle leakage is a rare complication after dissections of the lateral or subclavian axillary nodes for breast surgery. It is particularly unusual for chyle leakage to occur after minimally invasive dissection of the axillary nodes. Most cases of chyle leakage subside with conservative management, but some cases require surgery. Case report: An 80-year-old woman had invasive lobular cancer of the left breast (cT1 [1.7 cm], cN0, M0) for which she underwent breast-conservative surgery and biopsy of an axillary sentinel lymph node. Because two of the three sentinel lymph nodes tested positive for cancer, seven lateral axillary lymph nodes (level I) were subsequently removed for the additional sampling. On postoperative day 11, the patient visited our outpatient clinic because of swelling in her left axillary region and breast. Centesis of the axilla yielded 670 mL of milky fluid, which suggested chyle leakage. We commenced the conservative management at first; however, the persistent leakage made us perform the surgical management. The operation was not only ligating the opening of the chyle duct but needed total mastectomy because the postoperative pathology report showed invasive lobular carcinoma; the nipple and the caudal surgical margin of the lumpectomy were positive for cancer. The patient agreed to our recommendation of total mastectomy and surgical management of the chyle leakage. Ligation of the opening completely resolved the chylous discharge. Conclusion: We here report a case of large-volume leakage of chyle after sampling dissection of the lateral axillary lymph nodes for left breast cancer; the leakage persisted despite the standard conservative therapy but was resolved after surgical treatment. Chyle leakage can occur even after minimally invasive dissection of the axillary nodes.
- 4 February 2012
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 133 (2) , 685-693
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results
Aromatase inhibitor-associated bone loss has not been proved in the Japanese or Asian women. The aim of this study was to evaluate an upfront or delayed strategy of bone protection therapy with zoledronic acid administered at 4 mg every 6 months in postmenopausal Japanese women with early breast cancer to compare with results of the Z-FAST and ZO-FAST studies in western countries. Postmenopausal women with hormone receptor positive early breast cancer receiving adjuvant letrozole were randomly assigned to receive either upfront or delayed-start zoledronic acid (4 mg intravenously every 6 months). The delayed group received zoledronic acid when lumbar spine (L2–L4) bone mineral density (BMD) decreased to less than young adult mean −2.0SD or when a nontraumatic fracture occurred. The primary endpoint of this study was to compare the percent change in L1–L4 BMD at 12 months between the groups. Secondary endpoints included percent changes in L2–L4 and total hip (TH) BMD. The upfront and delayed groups included 94 and 95 patients, respectively. At 12 months, L1–L4, L2–L4, and TH BMD significantly decreased by 2.0, 2.4, and 2.4%, respectively, in the delayed group. L1–L4 BMD was 4.9% higher in the upfront group than in the delayed group (95% CI 3.9–5.8%; p < 0.001). L2–L4 BMD was 5.6% higher (95% CI 4.5–6.6%; p < 0.001), and TH BMD was 4.4% higher (95% CI 3.3–5.4%; p < 0.001). At 12 months, upfront zoledronic acid therapy prevented bone loss in postmenopausal Japanese women who were receiving adjuvant letrozole, confirming the Z-/ZO-FAST study results in western populations.
- 4 February 2012
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 133 (2) , 685-693
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results
Aromatase inhibitor-associated bone loss has not been proved in the Japanese or Asian women. The aim of this study was to evaluate an upfront or delayed strategy of bone protection therapy with zoledronic acid administered at 4 mg every 6 months in postmenopausal Japanese women with early breast cancer to compare with results of the Z-FAST and ZO-FAST studies in western countries. Postmenopausal women with hormone receptor positive early breast cancer receiving adjuvant letrozole were randomly assigned to receive either upfront or delayed-start zoledronic acid (4 mg intravenously every 6 months). The delayed group received zoledronic acid when lumbar spine (L2–L4) bone mineral density (BMD) decreased to less than young adult mean −2.0SD or when a nontraumatic fracture occurred. The primary endpoint of this study was to compare the percent change in L1–L4 BMD at 12 months between the groups. Secondary endpoints included percent changes in L2–L4 and total hip (TH) BMD. The upfront and delayed groups included 94 and 95 patients, respectively. At 12 months, L1–L4, L2–L4, and TH BMD significantly decreased by 2.0, 2.4, and 2.4%, respectively, in the delayed group. L1–L4 BMD was 4.9% higher in the upfront group than in the delayed group (95% CI 3.9–5.8%; p < 0.001). L2–L4 BMD was 5.6% higher (95% CI 4.5–6.6%; p < 0.001), and TH BMD was 4.4% higher (95% CI 3.3–5.4%; p < 0.001). At 12 months, upfront zoledronic acid therapy prevented bone loss in postmenopausal Japanese women who were receiving adjuvant letrozole, confirming the Z-/ZO-FAST study results in western populations.
- 1 January 2003
- Published by Atomic Energy Society of Japan in Journal of the Atomic Energy Society of Japan / Atomic Energy Society of Japan
- Vol. 45 (11) , 682-710
Irradiation Behavior of LWR High Burnup Fuel
本特集は, 財団法人原子力発電技術機構 (NUPEC) が国のプロジェクトとして1986年度より2001年度までの16年問にわたって行ってきた高燃焼度燃料の照射確証試験が終了したのを期して, 照射ふるまいを中心に, 高燃焼度化の経緯, 現状, 課題について整理・検討した結果を解説的に述べたものである。本プロジェクトでは, 製造データの採取から始まり原子炉での長期間照射を経て低燃焼度から高燃焼度に至る各段階で取り出した燃焼済み燃料の破壊および非破壊試験を行い, 試験炉での過渡時を模擬した出力急昇試験も含め, 燃料の照射ふるまいに係る幅広く詳細なデータベースを整備・蓄積してきた。このような大規模かつ系統的に行われた試験は世界的にも例がなく, 今後の高燃焼度燃料の安全性, 信頼性を評価する際の基礎となる貴重な成果を得ることができた。その中から燃料以外の専門の方にも興味を持っていただけると考える点に絞って, 高燃焼度燃料の照射ふるまいの世界を紹介する。
- 1 January 2003
- Published by Atomic Energy Society of Japan in Journal of the Atomic Energy Society of Japan / Atomic Energy Society of Japan
- Vol. 45 (11) , 682-710
Irradiation Behavior of LWR High Burnup Fuel
本特集は, 財団法人原子力発電技術機構 (NUPEC) が国のプロジェクトとして1986年度より2001年度までの16年問にわたって行ってきた高燃焼度燃料の照射確証試験が終了したのを期して, 照射ふるまいを中心に, 高燃焼度化の経緯, 現状, 課題について整理・検討した結果を解説的に述べたものである。本プロジェクトでは, 製造データの採取から始まり原子炉での長期間照射を経て低燃焼度から高燃焼度に至る各段階で取り出した燃焼済み燃料の破壊および非破壊試験を行い, 試験炉での過渡時を模擬した出力急昇試験も含め, 燃料の照射ふるまいに係る幅広く詳細なデータベースを整備・蓄積してきた。このような大規模かつ系統的に行われた試験は世界的にも例がなく, 今後の高燃焼度燃料の安全性, 信頼性を評価する際の基礎となる貴重な成果を得ることができた。その中から燃料以外の専門の方にも興味を持っていただけると考える点に絞って, 高燃焼度燃料の照射ふるまいの世界を紹介する。